Galux

News

This week's biofinancings include a nine-figure round for ILiAD, with Quantx Bio, Aerska, Galux, and Pandorum Technologies also raising new funds.

News

Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.